查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1513622

下一代輸液幫浦市場：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2033

Next Generation IV Infusion Pumps Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 350 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發佈了關於下一代輸液幫浦全球市場的綜合報告。該報告全面評估了主要市場動態，包括驅動因素、趨勢、機會和課題，並提供了有關市場結構的詳細見解。

關鍵見解

  • 下一代輸液幫浦市場規模（2024 年）：31 億美元
  • 預計市值（2033 年）：58 億美元
  • 全球市場成長率（2024-2033 年複合年增長率）：7.2%

下一代輸液幫浦市場：調查範圍

下一代輸液幫浦對於將藥物、液體和營養物質直接準確地輸送到患者的血液中至關重要。這些先進的泵浦融合了無線連接、電子健康記錄 (EHR) 整合和智慧警報系統等功能，以提高安全性和效率。市場提供多種幫浦類型，包括高容量幫浦、注射幫浦和用於醫院、門診診所、家庭保健機構和門診手術中心的門診幫浦。

推動市場成長的因素：

下一代輸液幫浦的全球市場受到幾個關鍵因素的推動，例如慢性病盛行率的增加推動了對先進輸液治療的需求。人口老化的加劇和醫院獲得性感染（HAI）發病率的上升進一步推動了市場的擴張。技術進步，例如具有增強安全功能的智慧輸液幫浦的市場開發，將透過提高治療準確性和患者治療效果來推動市場成長。此外，向家庭醫療保健和門診護理的轉變正在推動便攜式、易於使用的輸液設備的採用。

市場限制因素：

儘管成長前景廣闊，但下一代輸液幫浦市場面臨監管合規性、高設備成本和技術故障風險等課題。有關輸液幫浦的製造、銷售和使用的嚴格法規給製造商帶來了合規負擔，影響了市場進入障礙和營運成本。此外，先進輸液系統的高成本以及對潛在設備故障和錯誤的擔憂給市場滲透帶來了課題，特別是在資源有限的環境中。解決這些監管和經濟障礙需要行業利益相關者和政策制定者之間的合作，以確保獲得安全且負擔得起的輸液解決方案。

市場機會：

由於技術創新、改善的醫療基礎設施和不斷發展的病患照護模式，下一代輸液幫浦市場提供了巨大的成長機會。遠端監控和遠距醫療平台等數位健康技術的集成，增加了患者接受輸液治療的機會，並提高了治療依從性和結果。此外，輸液幫浦在傳統醫療保健環境之外的使用越來越多，例如緊急醫療服務和軍事醫學，正在擴大市場範圍。戰略合作夥伴關係、研發投資以及推出經濟高效且易於使用的輸液解決方案對於利用新的商機並在動態的醫療保健領域保持市場領先地位至關重要。

本報告解決的關鍵問題

  • 推動下一代輸液幫浦市場全球成長的關鍵因素是什麼？
  • 哪些類型的幫浦和應用正在推動輸液幫浦在各種醫療保健環境中的採用？
  • 由於技術進步，下一代輸液幫浦市場的競爭格局將會發生怎樣的變化？
  • 誰是下一代輸液幫浦市場的主要參與者？ 他們採取了哪些策略來維持市場地位？
  • 全球新一代輸液幫浦市場的新趨勢與未來前景如何？

目錄

第 1 章執行摘要

第二章市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包含/排除

第三章主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第 4 章關鍵成功因素

  • 主要品牌佔有率/已安裝設備的偏好
  • 新產品發佈
  • 監管場景
  • 報銷情況
  • 杵分析
  • 波特的分析
  • 價值鏈分析
  • 主要促銷策略：依製造商分類

第五章市場背景

  • 宏觀經濟因素
  • 預測因子 - 相關性和影響
  • 市場動態

第 6 章 COVID-19 危機分析

  • 新冠肺炎 (COVID-19) 與影響分析
    • 收入：依泵浦類型劃分
    • 收入：依用途分類
    • 收入：依最終用戶分類
    • 依地區劃分的收入
  • 2024 年市場情景

第七章全球新一代輸液幫浦市場需求分析

  • 2019-2023 年過去的市場銷售（單位）分析
  • 2024-2033 年當前及未來市場銷售（單位）預測
    • 年成長趨勢分析

第 8 章全球新一代輸液幫浦市場 - 價格分析

  • 區域價格分析：依泵浦類型
  • 價格明細
    • 製造商級別
    • 經銷商級
  • 世界平均價格分析基準
  • 定價假設

第九章全球新一代輸液幫浦市場需求分析（金額或規模，十億美元）

  • 2019-2023 年歷史市值分析（十億美元）
  • 2024-2033 年當前及未來市場價值（十億美元）預測
    • 年成長趨勢分析
    • 絕對數量機會分析

第 10 章全球新一代輸液幫浦市場分析：依幫浦類型

  • 簡介/主要發現
  • 2019-2023 年依泵浦類型劃分的歷史市場規模（十億美元）和銷售量（單位）分析
  • 2024-2033 年依泵浦類型劃分的當前和未來市場規模（十億美元）和銷售（台）分析和預測
    • 大容量輸液系統
    • 注射器注射系統
    • 電子攜帶式輸液系統
    • 病人自我鎮痛泵
    • 一次性彈性體輸液系統
    • 植入式輸液系統
    • MRI 相容靜脈輸液系統
    • 拋棄式靜脈注射
  • 市場吸引力分析：依泵類型

第 11 章全球新一代輸液幫浦市場分析：依應用

  • 簡介/主要發現
  • 2019-2023 年依應用劃分的歷史市場規模（十億美元）分析
  • 2024-2033 年當前和未來市場規模（依應用劃分）的分析和預測（十億美元）
    • 臨床營養
    • 疼痛管理
    • 化療
    • 抗生素管理
    • 其他
  • 市場吸引力分析：依應用分類

第 12 章全球新一代輸液幫浦市場分析：依最終使用者劃分

  • 簡介/主要發現
  • 2019-2023 年最終用戶歷史市場規模（十億美元）分析
  • 2024-2033 年最終用戶當前和未來市場規模（十億美元）的分析和預測
    • 醫院
    • 門診手術中心
    • 居家照護環境
    • 診斷中心
    • 其他
  • 市場吸引力分析：依最終用戶分類

第 13 章全球下一代輸液幫浦市場分析：依地區

  • 簡介
  • 2019-2023 年依地區歷史市場規模（十億美元）及交易量（單位）分析
  • 2024-2033 年依地區劃分的當前和未來市場規模（十億美元）和銷售（單位）分析和預測
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東和非洲 (MEA)
  • 市場吸引力分析：依地區劃分

第14章北美新一代輸液幫浦市場分析

第十五章拉丁美洲下一代輸液幫浦市場分析

第十六章歐洲新一代輸液幫浦市場分析

第十七章南亞新一代輸液幫浦市場分析

第十八章東亞地區新一代輸液幫浦市場分析

第十九章大洋洲新一代輸液幫浦市場分析

第 20 章中東和非洲 (MEA) 新一代輸液幫浦市場分析

第21章市場結構分析

  • 市場分析：依公司層級
  • 主要公司市佔率分析
  • 市場集中度
  • 市場現況分析

第22章競爭分析

  • 競爭對手儀表板
  • 競爭基準
  • 衝突詳情
    • Gamastech SRL
    • Ambu A/S
    • Summit Medical Products, Inc.
    • Nipro Corporation
    • Terumo Corporation
    • Medtronic Plc.
    • Zyno Medical
    • Baxter International Inc.
    • Fresenius Kabi AG
    • B. Braun Melsungen AG
    • Becton, Dickinson Company（CareFusion）
    • Smiths Medical（Smiths Group plc.）
    • Hospira Inc.
    • iRadimed Corporation
    • vTitan

第 23 章先決條件與使用的縮寫

第24章研究方法

簡介目錄
Product Code: PMRREP15781

Persistence Market Research has recently released a comprehensive report on the worldwide market for next generation IV infusion pumps. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Next Generation IV Infusion Pumps Market Size (2024E): USD 3.1 Billion
  • Projected Market Value (2033F): USD 5.8 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 7.2%

Next Generation IV Infusion Pumps Market - Report Scope:

Next generation IV infusion pumps are essential for the precise delivery of medications, fluids, and nutrients directly into a patient's bloodstream. These advanced pumps incorporate features such as wireless connectivity, integration with electronic health records (EHRs), and smart alarm systems to enhance safety and efficiency. The market serves hospitals, outpatient clinics, homecare settings, and ambulatory surgical centers, offering a variety of pump types, including large volume pumps, syringe pumps, and ambulatory pumps.

Market Growth Drivers:

The global next generation IV infusion pumps market is propelled by several key factors, including the increasing prevalence of chronic diseases, which drives the demand for advanced infusion therapy. The growing aging population and rising incidence of hospital-acquired infections (HAIs) further fuel market expansion. Technological advancements, such as the development of smart infusion pumps with enhanced safety features, promote market growth by improving treatment accuracy and patient outcomes. Additionally, the shift towards home-based healthcare and outpatient care supports the adoption of portable and user-friendly infusion devices.

Market Restraints:

Despite promising growth prospects, the next generation IV infusion pumps market faces challenges related to regulatory compliance, high device costs, and the risk of technical malfunctions. Stringent regulations governing the manufacturing, marketing, and use of infusion pumps impose compliance burdens on manufacturers, affecting market entry barriers and operational costs. Furthermore, the high cost of advanced infusion systems and concerns about potential device failures or errors pose challenges for market penetration, particularly in resource-constrained settings. Addressing these regulatory and economic barriers requires collaboration between industry stakeholders and policymakers to ensure access to safe and affordable infusion solutions.

Market Opportunities:

The next generation IV infusion pumps market presents significant growth opportunities driven by technological innovations, healthcare infrastructure improvements, and evolving patient care models. The integration of digital health technologies, such as remote monitoring and telehealth platforms, enhances patient access to infusion therapy and improves treatment adherence and outcomes. Additionally, the expanding application of infusion pumps beyond traditional healthcare settings, including in emergency medical services and military medicine, broadens the market scope. Strategic partnerships, investment in research and development, and the introduction of cost-effective and user-friendly infusion solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic healthcare landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the next generation IV infusion pumps market globally?
  • Which pump types and applications are driving infusion pump adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the next generation IV infusion pumps market?
  • Who are the key players contributing to the next generation IV infusion pumps market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global next generation IV infusion pumps market?

Competitive Intelligence and Business Strategy:

Leading players in the global next generation IV infusion pumps market, including Baxter International Inc., B. Braun Melsungen AG, and ICU Medical, Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced infusion solutions, including wireless-enabled pumps, integration with hospital information systems, and portable infusion devices, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical device distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving infusion therapy landscape.

Key Companies Profiled:

  • Gamastech S.R.L
  • Ambu A/S
  • Summit Medical Products, Inc.
  • Nipro Corporation
  • Terumo Corporation
  • Medtronic Plc.
  • Zyno Medical
  • Baxter International Inc.
  • Fresenius Kabi AG
  • B. Braun Melsungen AG
  • Becton, Dickinson Company (CareFusion)
  • Smith's Medical (Smiths Group plc.)
  • Hospira Inc.
  • iRadimed Corporation
  • vTitan

Key Segments Covered in Next-Generation IV Infusion Pumps Industry Research

Type of Pumps:

  • Large Volumetric Infusion Systems
  • Syringe Infusion Systems
  • Electronic-Ambulatory Infusion Systems
  • Patient Controlled Analgesia Pumps
  • Disposable Elastomeric Infusion Systems
  • Implantable Infusion Systems
  • MRI-Compatible IV Infusion Systems
  • IV Disposables

Application:

  • Clinical Nutrition
  • Pain Management
  • Chemotherapy
  • Antibiotic Management

End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Diagnostic Centers

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions & Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key Brand Share/Preference of Equipment Installed
  • 4.2. New Product Launches
  • 4.3. Regulatory Scenario
  • 4.4. Reimbursement Landscape
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis
  • 4.7. Value Chain Analysis
  • 4.8. Key Promotional Strategies by Manufacturers

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Global Injectable Drug Delivery Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. Technological Advancements in Next Generation IV Infusion Pumps
    • 5.2.3. New Product Launches
    • 5.2.4. Cost of Products
    • 5.2.5. Rising Cardiac Diseases
    • 5.2.6. Growing Adoption Rate
    • 5.2.7. Strategic Mergers and Acquisitions Among Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue By Type of Pumps
    • 6.1.2. Revenue By Application
    • 6.1.3. Revenue By End User
    • 6.1.4. Revenue By Region
  • 6.2. 2024 Market Scenario

7. Global Next Generation IV Infusion Pumps Market Demand Volume Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Next Generation IV Infusion Pumps Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By-Type of Pumps
  • 8.2. Pricing Break Up
    • 8.2.1. Manufacturer Level
    • 8.2.2. Distributor Level
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Next Generation IV Infusion Pumps Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033, By Type of Pumps

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Type of Pumps, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Type of Pumps, 2024-2033
    • 10.3.1. Large Volumetric Infusion Systems
    • 10.3.2. Syringe Infusion Systems
    • 10.3.3. Electronic-Ambulatory Infusion Systems
    • 10.3.4. Patient Controlled Analgesia Pumps
    • 10.3.5. Disposable Elastomeric Infusion Systems
    • 10.3.6. Implantable Infusion Systems
    • 10.3.7. MRI-Compatible IV Infusion Systems
    • 10.3.8. IV Disposables
  • 10.4. Market Attractiveness Analysis By Type of Pumps

11. Global Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033, by Application

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
    • 11.3.1. Clinical Nutrition
    • 11.3.2. Pain Management
    • 11.3.3. Chemotherapy
    • 11.3.4. Antibiotic Management
    • 11.3.5. Others
  • 11.4. Market Attractiveness Analysis By Application

12. Global Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033, by End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Ambulatory Surgical Centers
    • 12.3.3. Homecare Settings
    • 12.3.4. Diagnostic Centers
    • 12.3.5. Others
  • 12.4. Market Attractiveness Analysis By End User

13. Global Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 14.4.1. By Country
      • 14.4.1.1. U.S.
      • 14.4.1.2. Canada
    • 14.4.2. By Type of Pumps
    • 14.4.3. By Application
    • 14.4.4. By End User
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Type of Pumps
    • 14.5.3. By Application
    • 14.5.4. By End User
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Market Trends
  • 14.9. Country Level Analysis & Forecast
    • 14.9.1. U.S. Next Generation IV Infusion Pumps Market
      • 14.9.1.1. Introduction
      • 14.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.9.1.2.1. By Type of Pumps
        • 14.9.1.2.2. By Application
        • 14.9.1.2.3. By End User
    • 14.9.2. Canada Next Generation IV Infusion Pumps Market
      • 14.9.2.1. Introduction
      • 14.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.9.2.2.1. By Type of Pumps
        • 14.9.2.2.2. By Application
        • 14.9.2.2.3. By End User

15. Latin America Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 15.4.1. By Country
      • 15.4.1.1. Brazil
      • 15.4.1.2. Mexico
      • 15.4.1.3. Argentina
      • 15.4.1.4. Rest of Latin America
    • 15.4.2. By Type of Pumps
    • 15.4.3. By Application
    • 15.4.4. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Type of Pumps
    • 15.5.3. By Application
    • 15.5.4. By End User
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Market Trends
  • 15.9. Country Level Analysis & Forecast
    • 15.9.1. Brazil Next Generation IV Infusion Pumps Market
      • 15.9.1.1. Introduction
      • 15.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.9.1.2.1. By Type of Pumps
        • 15.9.1.2.2. By Application
        • 15.9.1.2.3. By End User
    • 15.9.2. Argentina Next Generation IV Infusion Pumps Market
      • 15.9.2.1. Introduction
      • 15.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.9.2.2.1. By Type of Pumps
        • 15.9.2.2.2. By Application
        • 15.9.2.2.3. By End User
    • 15.9.3. Mexico Next Generation IV Infusion Pumps Market
      • 15.9.3.1. Introduction
      • 15.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.9.3.2.1. By Type of Pumps
        • 15.9.3.2.2. By Application
        • 15.9.3.2.3. By End User

16. Europe Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 16.4.1. By Country
      • 16.4.1.1. Germany
      • 16.4.1.2. Italy
      • 16.4.1.3. France
      • 16.4.1.4. U.K.
      • 16.4.1.5. Spain
      • 16.4.1.6. BENELUX
      • 16.4.1.7. Russia
      • 16.4.1.8. Rest of Europe
    • 16.4.2. By Type of Pumps
    • 16.4.3. By Application
    • 16.4.4. By End User
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Type of Pumps
    • 16.5.3. By Application
    • 16.5.4. By End User
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Market Trends
  • 16.9. Country Level Analysis & Forecast
    • 16.9.1. Germany Next Generation IV Infusion Pumps Market
      • 16.9.1.1. Introduction
      • 16.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.1.2.1. By Type of Pumps
        • 16.9.1.2.2. By Application
        • 16.9.1.2.3. By End User
    • 16.9.2. France Next Generation IV Infusion Pumps Market
      • 16.9.2.1. Introduction
      • 16.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.2.2.1. By Type of Pumps
        • 16.9.2.2.2. By Application
        • 16.9.2.2.3. By End User
    • 16.9.3. Italy Next Generation IV Infusion Pumps Market
      • 16.9.3.1. Introduction
      • 16.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.3.2.1. By Type of Pumps
        • 16.9.3.2.2. By Application
        • 16.9.3.2.3. By End User
    • 16.9.4. Spain Next Generation IV Infusion Pumps Market
      • 16.9.4.1. Introduction
      • 16.9.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.4.2.1. By Type of Pumps
        • 16.9.4.2.2. By Application
        • 16.9.4.2.3. By End User
    • 16.9.5. U.K. Next Generation IV Infusion Pumps Market
      • 16.9.5.1. Introduction
      • 16.9.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.5.2.1. By Type of Pumps
        • 16.9.5.2.2. By Application
        • 16.9.5.2.3. By End User
    • 16.9.6. BENELUX Next Generation IV Infusion Pumps Market
      • 16.9.6.1. Introduction
      • 16.9.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.6.2.1. By Type of Pumps
        • 16.9.6.2.2. By Application
        • 16.9.6.2.3. By End User
    • 16.9.7. Russia Next Generation IV Infusion Pumps Market
      • 16.9.7.1. Introduction
      • 16.9.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.9.7.2.1. By Type of Pumps
        • 16.9.7.2.2. By Application
        • 16.9.7.2.3. By End User

17. South Asia Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 17.4.1. By Country
      • 17.4.1.1. India
      • 17.4.1.2. Thailand
      • 17.4.1.3. Indonesia
      • 17.4.1.4. Malaysia
      • 17.4.1.5. Rest of South Asia
    • 17.4.2. By Type of Pumps
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Type of Pumps
    • 17.5.3. By Application
    • 17.5.4. By End User
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Market Trends
  • 17.9. Country Level Analysis & Forecast
    • 17.9.1. India Next Generation IV Infusion Pumps Market
      • 17.9.1.1. Introduction
      • 17.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.9.1.2.1. By Type of Pumps
        • 17.9.1.2.2. By Application
        • 17.9.1.2.3. By End User
    • 17.9.2. Indonesia Next Generation IV Infusion Pumps Market
      • 17.9.2.1. Introduction
      • 17.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.9.2.2.1. By Type of Pumps
        • 17.9.2.2.2. By Application
        • 17.9.2.2.3. By End User
    • 17.9.3. Malaysia Next Generation IV Infusion Pumps Market
      • 17.9.3.1. Introduction
      • 17.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.9.3.2.1. By Type of Pumps
        • 17.9.3.2.2. By Application
        • 17.9.3.2.3. By End User
    • 17.9.4. Thailand Next Generation IV Infusion Pumps Market
      • 17.9.4.1. Introduction
      • 17.9.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.9.4.2.1. By Type of Pumps
        • 17.9.4.2.2. By Application
        • 17.9.4.2.3. By End User

18. East Asia Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 18.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 18.4.1. By Country
      • 18.4.1.1. China
      • 18.4.1.2. Japan
      • 18.4.1.3. South Korea
    • 18.4.2. By Type of Pumps
    • 18.4.3. By Application
    • 18.4.4. By End User
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Type of Pumps
    • 18.5.3. By Application
    • 18.5.4. By End User
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Market Trends
  • 18.9. Country Level Analysis & Forecast
    • 18.9.1. China Next Generation IV Infusion Pumps Market
      • 18.9.1.1. Introduction
      • 18.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.9.1.2.1. By Type of Pumps
        • 18.9.1.2.2. By Application
        • 18.9.1.2.3. By End User
    • 18.9.2. Japan Next Generation IV Infusion Pumps Market
      • 18.9.2.1. Introduction
      • 18.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.9.2.2.1. By Type of Pumps
        • 18.9.2.2.2. By Application
        • 18.9.2.2.3. By End User
    • 18.9.3. South Korea Next Generation IV Infusion Pumps Market
      • 18.9.3.1. Introduction
      • 18.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.9.3.2.1. By Type of Pumps
        • 18.9.3.2.2. By Application
        • 18.9.3.2.3. By End User

19. Oceania Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Pricing Analysis
  • 19.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 19.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 19.4.1. By Country
      • 19.4.1.1. Australia
      • 19.4.1.2. New Zealand
    • 19.4.2. By Type of Pumps
    • 19.4.3. By Application
    • 19.4.4. By End User
  • 19.5. Market Attractiveness Analysis
    • 19.5.1. By Country
    • 19.5.2. By Type of Pumps
    • 19.5.3. By Application
    • 19.5.4. By End User
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Market Trends
  • 19.9. Country Level Analysis & Forecast
    • 19.9.1. Australia Next Generation IV Infusion Pumps Market
      • 19.9.1.1. Introduction
      • 19.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.9.1.2.1. By Type of Pumps
        • 19.9.1.2.2. By Application
        • 19.9.1.2.3. By End User
    • 19.9.2. New Zealand Next Generation IV Infusion Pumps Market
      • 19.9.2.1. Introduction
      • 19.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.9.2.2.1. By Type of Pumps
        • 19.9.2.2.2. By Application
        • 19.9.2.2.3. By End User

20. Middle East and Africa (MEA) Next Generation IV Infusion Pumps Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Pricing Analysis
  • 20.3. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 20.4. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis Forecast By Market Taxonomy, 2024-2033
    • 20.4.1. By Country
      • 20.4.1.1. GCC Countries
      • 20.4.1.2. Turkey
      • 20.4.1.3. North Africa
      • 20.4.1.4. South Africa
      • 20.4.1.5. Rest of Middle East and Africa
    • 20.4.2. By Type of Pumps
    • 20.4.3. By Application
    • 20.4.4. By End User
  • 20.5. Market Attractiveness Analysis
    • 20.5.1. By Country
    • 20.5.2. By Type of Pumps
    • 20.5.3. By Application
    • 20.5.4. By End User
  • 20.6. Key Market Participants - Intensity Mapping
  • 20.7. Drivers and Restraints - Impact Analysis
  • 20.8. Market Trends
  • 20.9. Country Level Analysis & Forecast
    • 20.9.1. GCC Countries Next Generation IV Infusion Pumps Market
      • 20.9.1.1. Introduction
      • 20.9.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.9.1.2.1. By Type of Pumps
        • 20.9.1.2.2. By Application
        • 20.9.1.2.3. By End User
    • 20.9.2. Turkey Next Generation IV Infusion Pumps Market
      • 20.9.2.1. Introduction
      • 20.9.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.9.2.2.1. By Type of Pumps
        • 20.9.2.2.2. By Application
        • 20.9.2.2.3. By End User
    • 20.9.3. North Africa Next Generation IV Infusion Pumps Market
      • 20.9.3.1. Introduction
      • 20.9.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.9.3.2.1. By Type of Pumps
        • 20.9.3.2.2. By Application
        • 20.9.3.2.3. By End User
    • 20.9.4. South Africa Next Generation IV Infusion Pumps Market
      • 20.9.4.1. Introduction
      • 20.9.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.9.4.2.1. By Type of Pumps
        • 20.9.4.2.2. By Application
        • 20.9.4.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Concentration
  • 21.4. Market Presence Analysis
    • 21.4.1. Regional Footprint Analysis
    • 21.4.2. Product Footprint Analysis
    • 21.4.3. Channel Footprint Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Gamastech S.R.L
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Key Financials
      • 22.3.1.4. SWOT Analysis
      • 22.3.1.5. Sales Footprint
      • 22.3.1.6. Strategy Overview
      • 22.3.1.7. Key Developments
        • 22.3.1.7.1. Marketing Strategies
        • 22.3.1.7.2. Product Strategies
        • 22.3.1.7.3. Channel Strategies
    • 22.3.2. Ambu A/S
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Key Financials
      • 22.3.2.4. SWOT Analysis
      • 22.3.2.5. Sales Footprint
      • 22.3.2.6. Strategy Overview
      • 22.3.2.7. Key Developments
        • 22.3.2.7.1. Marketing Strategies
        • 22.3.2.7.2. Product Strategies
        • 22.3.2.7.3. Channel Strategies
    • 22.3.3. Summit Medical Products, Inc.
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Key Financials
      • 22.3.3.4. SWOT Analysis
      • 22.3.3.5. Sales Footprint
      • 22.3.3.6. Strategy Overview
      • 22.3.3.7. Key Developments
        • 22.3.3.7.1. Marketing Strategies
        • 22.3.3.7.2. Product Strategies
        • 22.3.3.7.3. Channel Strategies
    • 22.3.4. Nipro Corporation
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Key Financials
      • 22.3.4.4. SWOT Analysis
      • 22.3.4.5. Sales Footprint
      • 22.3.4.6. Strategy Overview
      • 22.3.4.7. Key Developments
        • 22.3.4.7.1. Marketing Strategies
        • 22.3.4.7.2. Product Strategies
        • 22.3.4.7.3. Channel Strategies
    • 22.3.5. Terumo Corporation
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Key Financials
      • 22.3.5.4. SWOT Analysis
      • 22.3.5.5. Sales Footprint
      • 22.3.5.6. Strategy Overview
      • 22.3.5.7. Key Developments
        • 22.3.5.7.1. Marketing Strategies
        • 22.3.5.7.2. Product Strategies
        • 22.3.5.7.3. Channel Strategies
    • 22.3.6. Medtronic Plc.
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Key Financials
      • 22.3.6.4. SWOT Analysis
      • 22.3.6.5. Sales Footprint
      • 22.3.6.6. Strategy Overview
      • 22.3.6.7. Key Developments
        • 22.3.6.7.1. Marketing Strategies
        • 22.3.6.7.2. Product Strategies
        • 22.3.6.7.3. Channel Strategies
    • 22.3.7. Zyno Medical
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Key Financials
      • 22.3.7.4. SWOT Analysis
      • 22.3.7.5. Sales Footprint
      • 22.3.7.6. Strategy Overview
      • 22.3.7.7. Key Developments
        • 22.3.7.7.1. Marketing Strategies
        • 22.3.7.7.2. Product Strategies
        • 22.3.7.7.3. Channel Strategies
    • 22.3.8. Baxter International Inc.
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Key Financials
      • 22.3.8.4. SWOT Analysis
      • 22.3.8.5. Sales Footprint
      • 22.3.8.6. Strategy Overview
      • 22.3.8.7. Key Developments
        • 22.3.8.7.1. Marketing Strategies
        • 22.3.8.7.2. Product Strategies
        • 22.3.8.7.3. Channel Strategies
    • 22.3.9. Fresenius Kabi AG
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Key Financials
      • 22.3.9.4. SWOT Analysis
      • 22.3.9.5. Sales Footprint
      • 22.3.9.6. Strategy Overview
      • 22.3.9.7. Key Developments
        • 22.3.9.7.1. Marketing Strategies
        • 22.3.9.7.2. Product Strategies
        • 22.3.9.7.3. Channel Strategies
    • 22.3.10. B. Braun Melsungen AG
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Key Financials
      • 22.3.10.4. SWOT Analysis
      • 22.3.10.5. Sales Footprint
      • 22.3.10.6. Strategy Overview
      • 22.3.10.7. Key Developments
        • 22.3.10.7.1. Marketing Strategies
        • 22.3.10.7.2. Product Strategies
        • 22.3.10.7.3. Channel Strategies
    • 22.3.11. Becton, Dickinson Company (CareFusion)
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Key Financials
      • 22.3.11.4. SWOT Analysis
      • 22.3.11.5. Sales Footprint
      • 22.3.11.6. Strategy Overview
      • 22.3.11.7. Key Developments
        • 22.3.11.7.1. Marketing Strategies
        • 22.3.11.7.2. Product Strategies
        • 22.3.11.7.3. Channel Strategies
    • 22.3.12. Smiths Medical (Smiths Group plc.)
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Key Financials
      • 22.3.12.4. SWOT Analysis
      • 22.3.12.5. Sales Footprint
      • 22.3.12.6. Strategy Overview
      • 22.3.12.7. Key Developments
        • 22.3.12.7.1. Marketing Strategies
        • 22.3.12.7.2. Product Strategies
        • 22.3.12.7.3. Channel Strategies
    • 22.3.13. Hospira Inc.
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Key Financials
      • 22.3.13.4. SWOT Analysis
      • 22.3.13.5. Sales Footprint
      • 22.3.13.6. Strategy Overview
      • 22.3.13.7. Key Developments
        • 22.3.13.7.1. Marketing Strategies
        • 22.3.13.7.2. Product Strategies
        • 22.3.13.7.3. Channel Strategies
    • 22.3.14. iRadimed Corporation
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Key Financials
      • 22.3.14.4. SWOT Analysis
      • 22.3.14.5. Sales Footprint
      • 22.3.14.6. Strategy Overview
      • 22.3.14.7. Key Developments
        • 22.3.14.7.1. Marketing Strategies
        • 22.3.14.7.2. Product Strategies
        • 22.3.14.7.3. Channel Strategies
    • 22.3.15. vTitan
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Key Financials
      • 22.3.15.4. SWOT Analysis
      • 22.3.15.5. Sales Footprint
      • 22.3.15.6. Strategy Overview
      • 22.3.15.7. Key Developments
        • 22.3.15.7.1. Marketing Strategies
        • 22.3.15.7.2. Product Strategies
        • 22.3.15.7.3. Channel Strategies

23. Assumptions and Acronyms Used

24. Research Methodology